首页 | 本学科首页   官方微博 | 高级检索  
检索        

麦芽糖注射液对2型糖尿病糖脂代谢和胰岛素分泌影响的研究
引用本文:潘海林,王乃尊,蒋飞霞,苏宏业,黎英荣,肖常青.麦芽糖注射液对2型糖尿病糖脂代谢和胰岛素分泌影响的研究[J].中国药物与临床,2005,5(11):822-824.
作者姓名:潘海林  王乃尊  蒋飞霞  苏宏业  黎英荣  肖常青
作者单位:广西医科大学第一附属医院代谢糖尿病中心,530021
摘    要:目的探讨麦芽糖注射液对2型糖尿病血糖、脂质代谢及胰岛素分泌的影响,并评价其供能的有效性。方法59例2型糖尿病患者随机分为麦牙糖组和氯化钠组,分别静脉输注10%麦芽糖注射液或0.9%氯化钠注射液各500 ml。观察输注前后血糖(BG)、血C肽、血游离脂肪酸(FFA)、血酮体、尿糖及尿酮变化。结果①麦芽糖组(A组)用药后1、2、3、5h静脉血糖均较用药前有所增加,其增量分别为(0.04±0.82)mmol/L、(0.39±1.19)mmol/L、(0.50±1.37)mmol/L、(0.14±1.24)mmo1/L,氯化钠组(B组)则较用药前有所下降,其血糖下降值各为(0.93±1.05)mmol/L、(1.12±1.05)mmol/L、(1.28±1.05)mmol/L、(1.66±1.20)mmol/L,两组比较差异有统计学意义(P<0.01);②两组用药后5 h内血浆游离脂肪酸(FFA)及血酮体均有下降,但氯化钠组下降不如麦芽糖果组明显,两组比较差异有统计学意义;③麦芽糖组用药后C肽及尿糖水平有所增加,尿酮治疗前后变化两组差异无统计学意义(P>0.05)。结论麦芽糖注射液用于2型糖尿病患者,在提供能量时未引起血、尿酮体升高,还能降低血FFA浓度,虽然开始治疗5h内血糖水平有所提高,但其升值幅度不大,故在监测血糖情况下,使用是安全的。

关 键 词:糖尿病  2型  麦芽糖  血糖  脂肪酸类  非酯化
收稿时间:2005-07-04
修稿时间:2005年7月4日

A study on maltose injection to influence glycolipid metabolism and insulin secretion in type 2 diabetic
PAN Hai-lin,WANG Nai-zun,JIANG Fei-xia,SU Hong-ye,LI Ying-rong,XIAO Chang-qing.A study on maltose injection to influence glycolipid metabolism and insulin secretion in type 2 diabetic[J].Chinese Remedies & Clinics,2005,5(11):822-824.
Authors:PAN Hai-lin  WANG Nai-zun  JIANG Fei-xia  SU Hong-ye  LI Ying-rong  XIAO Chang-qing
Abstract:Objective To observe the influence of the maltose injection in the treatment of type 2 diabetes mellitus on the levels of blood glucose(BG),free fatty acid(FFA),C-peptide,blood and urine ketone,and to evaluate its efficacy and safety.Methods Fifty-nine patients with type 2 diabetes mellitus were divided into two groups and received randomizd,placebo-controlled study with maltose injection(group A) or sodium chloride(group B).Results Maltose injection increased slightly the blood glucose levels in the first 5 hours after treatment compared with sodium chloride group;the elevated value were(0.04±0.82)mmol/L,(0.39±1.19)mmol/L,(0.50±1.37)mmol/L,(0.14±1.24)mmo1/L in group A,and the decreased value were(0.93±1.05)mmol/L,(1.12±1.05)mmol/L,(1.28±1.05)mmol/L,(1.66±1.20)mmol/L in group B(P<0.01).The urine glucose levels were elevated 3 hours after the maltose injection.Free fatty acid(FFA) and blood ketone decreased in the both groups in the first 5 hours,especially in the maltose injection group.C-peptide value increased after treatment with maltose injection,urine ketone levels did not change markedly.Conclusion Maltose injection is a compatible fluid for type 2 diabetic patients;its energy-supply did not make the blood or urine keto-bodies run up,it even let the blood FFA have a drop;though its initial action made a five-hour high sugar level,the rise was mild;therefore under a blood sugar surveillance its use is safe.
Keywords:Diabetes mellitus  type 2  Maltose  Blood glucose  Fatty acids  nonesterified  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号